Emily Dodds has worked at Quotient Sciences for over five years, specialising in the design, execution, and review of Phase 1 clinical studies. Her expertise centres on clinical pharmacology programs, including first-in-human and drug-drug interaction studies.

As part of the Scientific Consulting department, Emily acts as a Science Lead across multiple programs, playing a key role in customer discussions and interpreting technical data packages to design tailored programs of work.

Emily holds an MSc in Clinical Pharmacology from King’s College London